Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Cohen

Showing results (81-90 of 174) with videos related to

Pageof 18
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 30, 2023
Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid AntibodiesHannah Cohen, David J Werring, Arvind Chandratheva, et al.
British Journal of Haematology|February 13, 2003
Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (Beta2GPI) polymorphism and anti-Beta2GPI antibodiesMichael J Nash, Raymond S Camilleri, Ri Liesner, et al.
Blood|June 4, 2011
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpuraMarie Scully, Vickie McDonald, Jamie Cavenagh, et al.
American Journal of Preventive Medicine|July 23, 2014
Environments perceived as obesogenic have lower residential property valuesAdam Drewnowski, Anju Aggarwal, Colin D Rehm, et al.
Thrombosis Research|January 24, 2012
Development and application of an automated chromogenic thrombin generation assay that is sensitive to defects in the protein C pathwayLaura Green, Omid Safa, Samuel J Machin, et al.
British Journal of Haematology|January 20, 2007
Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13Marie Scully, Hannah Cohen, Jamie Cavenagh, et al.
Lupus|May 6, 2026
Morbidity and mortality in primary versus secondary antiphospholipid syndrome: A single-center study using the 2023 ACR/EULAR criteriaRoni Meidan, Monica Angerri Nadal, Blanca Viejo Sosa, et al.
Journal of Epidemiology and Community Health|December 24, 2017
Associations between neighbourhood characteristics and depression: a twin studyHannah Cohen-Cline, Shirley A A Beresford, Wendy Elizabeth Barrington, et al.
Blood Reviews|September 1, 2019
The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APSThomas McDonnell, Chris Wincup, Ina Buchholz, et al.
Lupus|August 2, 2024
Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: A single centre retrospective studyPrabal Mittal, Marina Pacheco, Laura Trives-Folguera, et al.
Pageof 18

Showing results (81-90 of 174) with videos related to

Sort By:
Pageof 18
Journal of Thrombosis and Haemostasis : JTH|June 30, 2023
Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid AntibodiesHannah Cohen, David J Werring, Arvind Chandratheva, et al.
British Journal of Haematology|February 13, 2003
Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (Beta2GPI) polymorphism and anti-Beta2GPI antibodiesMichael J Nash, Raymond S Camilleri, Ri Liesner, et al.
Blood|June 4, 2011
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpuraMarie Scully, Vickie McDonald, Jamie Cavenagh, et al.
American Journal of Preventive Medicine|July 23, 2014
Environments perceived as obesogenic have lower residential property valuesAdam Drewnowski, Anju Aggarwal, Colin D Rehm, et al.
Thrombosis Research|January 24, 2012
Development and application of an automated chromogenic thrombin generation assay that is sensitive to defects in the protein C pathwayLaura Green, Omid Safa, Samuel J Machin, et al.
British Journal of Haematology|January 20, 2007
Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13Marie Scully, Hannah Cohen, Jamie Cavenagh, et al.
Lupus|May 6, 2026
Morbidity and mortality in primary versus secondary antiphospholipid syndrome: A single-center study using the 2023 ACR/EULAR criteriaRoni Meidan, Monica Angerri Nadal, Blanca Viejo Sosa, et al.
Journal of Epidemiology and Community Health|December 24, 2017
Associations between neighbourhood characteristics and depression: a twin studyHannah Cohen-Cline, Shirley A A Beresford, Wendy Elizabeth Barrington, et al.
Blood Reviews|September 1, 2019
The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APSThomas McDonnell, Chris Wincup, Ina Buchholz, et al.
Lupus|August 2, 2024
Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: A single centre retrospective studyPrabal Mittal, Marina Pacheco, Laura Trives-Folguera, et al.
Pageof 18